Page last updated: 2024-10-25

citalopram and Dyslipidemias

citalopram has been researched along with Dyslipidemias in 1 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colotto, M1
Vinci, F1
Vo Hong, N1
Raimo, O1
Castello, A1
Carnovale, A1
Paciaroni, A1
Coletta, P1

Reviews

1 review available for citalopram and Dyslipidemias

ArticleYear
[Effect of treatment with selective serotonin reuptake inhibitors on lipid profile: state of the art].
    La Clinica terapeutica, 2012, Volume: 163, Issue:1

    Topics: Antidepressive Agents; Citalopram; Depression; Depressive Disorder; Double-Blind Method; Dyslipidemi

2012